DAVID CORRY to Disease Progression
This is a "connection" page, showing publications DAVID CORRY has written about Disease Progression.
Connection Strength
0.160
-
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun. 2024 Jan 03; 15(1):216.
Score: 0.037
-
IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer. Cancer Immunol Res. 2018 06; 6(6):645-657.
Score: 0.025
-
Matrix remodeling in chronic lung diseases. Matrix Biol. 2018 11; 73:52-63.
Score: 0.024
-
Protective role of ?d T cells in cigarette smoke and influenza infection. Mucosal Immunol. 2018 05; 11(3):894-908.
Score: 0.024
-
Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1171-8.
Score: 0.021
-
Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression. Ann Am Thorac Soc. 2015 Nov; 12 Suppl 2:S164-8.
Score: 0.021
-
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004 Oct; 1(1):e8.
Score: 0.010